NEW YORK, June 26, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Hims & Hers Health, Inc. (NYSE: HIMS) for potential violations of the federal securities laws. If you invested in Hims & Hers, you are encouraged to obtain additional information by visiting: Click Here
SAN DIEGO, June 25, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Hims & Hers Health, Inc. (NYSE: HIMS) securities between April 29, 2025 and June 23, 2025, inclusive (the “Class Period”), have until August 25, 2025 to seek appointment as lead plaintiff of the Hims & Hers class action lawsuit. Captioned Sookdeo v. Hims & Hers Health, Inc., No. 25-cv-05315 (N.D. Cal.), the Hims & Hers class action lawsuit charges Hims & Hers and certain of Hims & Hers' top executives with violations of the Securities Exchange Act of 1934. A subsequently filed complaint is captioned Yaghsizian v. Hims & Hers Health, Inc., No. 25-cv-05321 (N.D. Cal.).
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), announces that it has filed a class action lawsuit in the United States District Court for the Northern District of California, captioned Sookdeo v. Hims & Hers Health, Inc., et al., Case No. 3:25-cv-05315, on behalf of persons and entities that purchased or otherwise acquired Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS) securities between April 29, 2025 and June 22, 2025, inclusive (the “Class Per.
6 Jun 2025 Date | | 0.01 Cons. EPS | - EPS |
5 May 2025 Date | | 0.12 Cons. EPS | 0.2 EPS |
24 Feb 2025 Date | | 0.22 Cons. EPS | 0.23 EPS |
4 Nov 2024 Date | | 0.04 Cons. EPS | 0.32 EPS |
5 Aug 2024 Date | | 0.04 Cons. EPS | 0.06 EPS |
6 Jun 2025 Date | | 0.01 Cons. EPS | - EPS |
5 May 2025 Date | | 0.12 Cons. EPS | 0.2 EPS |
24 Feb 2025 Date | | 0.22 Cons. EPS | 0.23 EPS |
4 Nov 2024 Date | | 0.04 Cons. EPS | 0.32 EPS |
5 Aug 2024 Date | | 0.04 Cons. EPS | 0.06 EPS |
Household & Personal Products Industry | Consumer Defensive Sector | Mr. Andrew Dudum CEO | XBER Exchange | US4330001060 ISIN |
US Country | 1,637 Employees | - Last Dividend | - Last Split | 13 Sep 2019 IPO Date |
Hims & Hers Health, Inc., based in San Francisco, California, operates as a telehealth platform connecting consumers with licensed healthcare professionals across the United States, the United Kingdom, and other international locations. The company leverages its websites and mobile application to offer a variety of carefully selected health and wellness products and services, both on prescription and over-the-counter basis. Its business model focuses on providing convenient access to ongoing healthcare services, including prescription medication refills and consultations with healthcare providers, as well as a wide range of wellness products through direct sales and wholesale partnerships.